The scientific objective of our team is to understand how the expression of the endocannabinoid system (SEC) in various neuronal types regulates differently the implementation of specific brain functions. ESA in the brain includes CB1 receptors, their endogenous lipid ligands, endocannabinoids (mainly arachidonoyl-ethanolamine, AEA, and 2-arachidonoyl-glycerol, 2-AG), and their synthesis and grading machinery.
The major consequence of the activation of CB1 receptors is the decrease in neuronal excitability and the reduction in the pre-synaptic release of the neurotransmitter. Since CB1 receivers are expressed on GABAergic and glutamatergic terminations where they negatively control inhibitory and excitatory transmissions, the location of these receivers could confer different or even opposite functions on the SEC on neuronal activity and behaviour. To understand the specific role of CB1 receptors in each neuronal population (inhibitory or exciting), we have developed advanced genetic tools that have allowed the conditional development of CB1 receptors from specific neuronal populations. Using these tools, we were able to study the consequences of the conditional delegation of CB1 receptors from GABAergic neurons or cortical glutamatergic neurons.
In recent years, we have obtained results that suggest the innovative idea that the SEC performs different functions according to the identity of the neural population in which CB1 receptors are expressed. Thus, CB1 receptors potted by glutamatergic cortical neurons are directly responsible for the classic neuroprotective and orexia functions attributed to the SEC and CB1 receptor agonists. Surprisingly, these functions are independent of the abundant expression of CB1 receptors in GABAergic neurons, the latter being unexpectedly at the origin of pro-ophobic and anorexigenic functions of the SEC.
These results, which provide new insight into the functional role of the SEC, are the basis for interesting publications. They are the cement on which we base our future plans to disseminate this polymodal action of the ESA and its functional impacts.
GLP-1 receptor (GLP-1R) agonists effectively improve glycemia and body weight in patients with type 2 diabetes and obesity, but have limited weight-lowering efficacy and minimal insulin sensitizing ac
Physical exercise, which can be addictogenic on its own, is considered a therapeutic alternative for drug craving. Exercise might thus share with drugs the ability to strengthen excitatory synapses on
Water intake is crucial for maintaining body fluid homeostasis and animals' survival [1-4]. In the brain, complex processes trigger thirst and drinking behavior [1-5]. The anterior wall of the third v
The recreational and medical use of cannabis is largely increasing worldwide. Cannabis use, however, can cause adverse side effects, so conducting innovative studies aimed to understand and potentiall
Recent surveys have revealed close links between cannabis and exercise. Specifically, cannabis usage before and/or after exercise is an increasingly common habit primarily aimed at boosting exercise p